These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 36547458)
1. Exploring the Role of Obesity in Dilated Cardiomyopathy Based on Bio-informatics Analysis. Wang X; Liu W; Li H; Ding J; Feng Y; Chen Z J Cardiovasc Dev Dis; 2022 Dec; 9(12):. PubMed ID: 36547458 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy. Liu Z; Song YN; Chen KY; Gao WL; Chen HJ; Liang GY World J Cardiol; 2022 May; 14(5):282-296. PubMed ID: 35702326 [TBL] [Abstract][Full Text] [Related]
3. An Robust Rank Aggregation and Least Absolute Shrinkage and Selection Operator Analysis of Novel Gene Signatures in Dilated Cardiomyopathy. Ma X; Mo C; Huang L; Cao P; Shen L; Gui C Front Cardiovasc Med; 2021; 8():747803. PubMed ID: 34970603 [No Abstract] [Full Text] [Related]
4. Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression. He B; Quan LP; Cai CY; Yu DY; Yan W; Wei QJ; Zhang Z; Huang XN; Liu L Front Cardiovasc Med; 2022; 9():973279. PubMed ID: 36148059 [TBL] [Abstract][Full Text] [Related]
5. Identification of endocrine-disrupting chemicals targeting key DCM-associated genes via bioinformatics and machine learning. Li S; Liu S; Sun X; Hao L; Gao Q Ecotoxicol Environ Saf; 2024 Apr; 274():116168. PubMed ID: 38460409 [TBL] [Abstract][Full Text] [Related]
6. Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis. Gan T; Hu J; Aledan AKO; Liu W; Li C; Lu S; Wang Y; Xu Q; Wang Y; Wang Z Front Immunol; 2023; 14():1049351. PubMed ID: 36733486 [TBL] [Abstract][Full Text] [Related]
7. Identification of dilated cardiomyopathy-linked key genes by bioinformatics methods and evaluating the impact of tannic acid and monosodium glutamate in rats. Karadas H; Tosun H; Ceylan H Biotechnol Appl Biochem; 2024 Sep; ():. PubMed ID: 39318238 [TBL] [Abstract][Full Text] [Related]
8. Investigating possible dilated cardiomyopathy targets via bioinformatic analysis. Zhou J; Wang X; Xiong W; Zhang M Am J Transl Res; 2023; 15(7):4788-4795. PubMed ID: 37560246 [TBL] [Abstract][Full Text] [Related]
9. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy. Zhang H; Huo J; Jiang W; Shan Q Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989 [TBL] [Abstract][Full Text] [Related]
10. Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis. Zhu T; Wang M; Quan J; Du Z; Li Q; Xie Y; Lin M; Xu C; Xie Y Front Genet; 2022; 13():874544. PubMed ID: 35646094 [No Abstract] [Full Text] [Related]
11. Identification of the Key Genes of Immune Infiltration in Dilated Cardiomyopathy. Qi B; Wang HY; Ma X; Chi YF; Gui C Int Heart J; 2023 Nov; 64(6):1054-1064. PubMed ID: 37967988 [TBL] [Abstract][Full Text] [Related]
12. Identification of senescence related hub genes and potential therapeutic compounds for dilated cardiomyopathy via comprehensive transcriptome analysis. Du C; Wang S; Shi X; Jing P; Wang H; Wang L Comput Biol Med; 2024 Sep; 179():108901. PubMed ID: 39029429 [TBL] [Abstract][Full Text] [Related]
13. Screening for immune-related biomarkers associated with myasthenia gravis and dilated cardiomyopathy based on bioinformatics analysis and machine learning. Zhou G; Wang S; Lin L; Lu K; Lin Z; Zhang Z; Zhang Y; Cheng D; Szeto K; Peng R; Luo C Heliyon; 2024 Apr; 10(7):e28446. PubMed ID: 38571624 [TBL] [Abstract][Full Text] [Related]
14. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods. Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479 [TBL] [Abstract][Full Text] [Related]
15. Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy. Yang Y; Liu P; Teng R; Liu F; Zhang C; Lu X; Ding Y Ann Transl Med; 2022 Mar; 10(6):348. PubMed ID: 35433958 [TBL] [Abstract][Full Text] [Related]
16. Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy Wang Z; Xia Q; Su W; Cao M; Sun Y; Zhang M; Chen W; Jiang T Front Cardiovasc Med; 2022; 9():824756. PubMed ID: 35282347 [TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes. Zheng J; Dong H; Zhang T; Ning J; Xu Y; Cai C Front Genet; 2022; 13():865052. PubMed ID: 35559024 [No Abstract] [Full Text] [Related]
18. Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq. Fang C; Lv Z; Yu Z; Wang K; Xu C; Li Y; Wang Y BMC Cardiovasc Disord; 2022 Jul; 22(1):320. PubMed ID: 35850644 [TBL] [Abstract][Full Text] [Related]
19. [Identify the characteristic genes of dilated cardiomyopathy and immune cell infiltration based on bioinformatics and machine learning]. Jiang C; Zhong G Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jan; 39(1):26-33. PubMed ID: 36631012 [TBL] [Abstract][Full Text] [Related]
20. Differences in T cell-associated serum markers between ischemic cardiomyopathy and dilated cardiomyopathy. Huang Y; Xuan L; Xu Q; Wang J; Liu J J Thorac Dis; 2024 Jul; 16(7):4655-4665. PubMed ID: 39144301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]